InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

FATE THERAPEUTICS INC

FATE Clue Score25
United States Fiscal year ends December CIK 0001434316 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

By person

7 insiders · 11 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Bahram Valamehr
President and CEO
—
$168.14K (3)
−$168.14K
591,815
0.4939%
$1.22M
+65.3%
Cindy Tahl
See Remarks
—
$154.76K (3)
−$154.76K
589,355
0.4919%
$1.21M
+72.1%
Kamal Adawi
Chief Financial Officer
—
$13.52K (1)
−$13.52K
93,418
0.0780%
$191.96K
—
Redmile Group, LLC entity
Director
—
—
—
12,884,277
10.75%
$26.47M
+0.7%
Jerome Charles Bressi
See Remarks
—
—
—
335,203
0.2798%
$688.78K
+21.4%
Robert S Epstein
Director
—
—
—
36,331
0.0303%
$74.65K
+220.6%
William H Rastetter
Director
—
—
—
36,331
0.0303%
$74.65K
+220.6%